Canada Life Portfolio holdings
AUM
$63.1B
1-Year Return
22.24%
This Quarter Return
+12.79%
1 Year Return
+22.24%
3 Year Return
+92.16%
5 Year Return
+162.31%
10 Year Return
+335.82%
AUM
$45.5B
AUM Growth
+$3.87B
(+9.3%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-7.25%
Top 10 Holdings %
Top 10 Hldgs %
22.97%
Holding
2,251
New
17
Increased
879
Reduced
1,035
Closed
90
Top Buys
| 1 |
AbbVie
ABBV
|
+$62.8M |
| 2 |
Amazon
AMZN
|
+$56.4M |
| 3 |
CRH
CRH
|
+$33.3M |
| 4 |
Kenvue
KVUE
|
+$31M |
| 5 |
Mastercard
MA
|
+$29M |
Top Sells
| 1 |
TSMC
TSM
|
+$1.05B |
| 2 |
Ryanair
RYAAY
|
+$627M |
| 3 |
NetEase
NTES
|
+$602M |
| 4 |
Pinduoduo
PDD
|
+$505M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$59.1M |
Sector Composition
| 1 | Technology | 28.07% |
| 2 | Financials | 12.85% |
| 3 | Healthcare | 12.76% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Madrigal Pharmaceuticals
MDGL
$9.59B
| $226K | ﹤0.01% |
982
-221
| -18% | -$50.9K |
|
1827
Melco Resorts & Entertainment
MLCO
$3.8B
| $226K | ﹤0.01% |
25,563
-85,489
| -77% | -$756K |
|
|
RDUS
1828
DELISTED
Radius Recycling
RDUS
| $225K | ﹤0.01% |
7,506
+3,278
| +78% | +$98.3K |
|
|
ALX
1829
Alexander's
ALX
$1.22B
| $222K | ﹤0.01% |
1,046
-1
| -0.1% | -$212 |
|
|
GOOD
1830
Gladstone Commercial Corp
GOOD
$598M
| $221K | ﹤0.01% |
16,805
-166
| -1% | -$2.18K |
|
1831
TELUS International
TIXT
$1.25B
| $221K | ﹤0.01% |
25,821
-11,282
| -30% | -$96.6K |
|
|
PETQ
1832
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $220K | ﹤0.01% |
+11,185
| New | +$220K |
|
1833
Baytex Energy
BTE
$1.83B
| $219K | ﹤0.01% |
66,241
| – | – |
|
1834
Rhythm Pharmaceuticals
RYTM
$6.66B
| $219K | ﹤0.01% |
4,796
+1,249
| +35% | +$57K |
|
|
PRMW
1835
DELISTED
Primo Water Corporation
PRMW
| $219K | ﹤0.01% |
14,646
-1,231
| -8% | -$18.4K |
|
1836
Krystal Biotech
KRYS
$3.98B
| $213K | ﹤0.01% |
1,731
| – | – |
|
1837
TG Therapeutics
TGTX
$5.05B
| $212K | ﹤0.01% |
12,471
| – | – |
|
1838
Ginkgo Bioworks
DNA
$609M
| $210K | ﹤0.01% |
3,133
+240
| +8% | +$16.1K |
|
1839
Veracyte
VCYT
$2.42B
| $210K | ﹤0.01% |
7,668
-506
| -6% | -$13.9K |
|
1840
Ameresco
AMRC
$1.48B
| $207K | ﹤0.01% |
6,557
+219
| +3% | +$6.91K |
|
1841
Denali Therapeutics
DNLI
$2.14B
| $207K | ﹤0.01% |
9,724
| – | – |
|
1842
Beam Therapeutics
BEAM
$2.01B
| $200K | ﹤0.01% |
7,429
+1,039
| +16% | +$28K |
|
1843
BioNTech
BNTX
$24.3B
| $200K | ﹤0.01% |
1,908
-860
| -31% | -$90.1K |
|
1844
Peoples Bancorp
PEBO
$1.09B
| $200K | ﹤0.01% |
5,969
+216
| +4% | +$7.24K |
|
|
CBAY
1845
DELISTED
Cymabay Therapeutics
CBAY
| $198K | ﹤0.01% |
8,424
| – | – |
|
1846
JELD-WEN Holding
JELD
$537M
| $196K | ﹤0.01% |
10,426
+1,260
| +14% | +$23.7K |
|
1847
Mueller Water Products
MWA
$3.86B
| $196K | ﹤0.01% |
13,701
| – | – |
|
1848
Surgery Partners
SGRY
$2.75B
| $194K | ﹤0.01% |
6,094
| – | – |
|
|
HTLF
1849
DELISTED
Heartland Financial USA, Inc.
HTLF
| $193K | ﹤0.01% |
5,138
-2,635
| -34% | -$99K |
|
1850
Vermilion Energy
VET
$1.18B
| $189K | ﹤0.01% |
15,671
-8,193
| -34% | -$98.8K |
|